Trial Profile
Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naive Infected Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 18 Sep 2017 Results assessing HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV subjects (n=22), published in the Journal of Clinical Endocrinology and Metabolism
- 22 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.